140 filings
Page 2 of 7
424B5
pcqdr4
31 May 23
Prospectus supplement for primary offering
5:19pm
EFFECT
f4lte10kez4yw7ah8
30 May 23
Notice of effectiveness
12:15am
CORRESP
mb03v0
24 May 23
Correspondence with SEC
12:00am
UPLOAD
ox97im3jdvj5o
18 May 23
Letter from SEC
12:00am
8-K
45o6tqfp7pzydr
11 May 23
Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update
7:25am
S-8
qmc3 xuhpruf
28 Apr 23
Registration of securities for employees
5:10pm
ARS
8xyh19
28 Apr 23
Annual report to shareholders
5:01pm
DEFA14A
lklxz
28 Apr 23
Additional proxy soliciting materials
4:20pm
8-K
u15odzn
31 Mar 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9:29am
8-K
qejvq76taa411by9w
29 Mar 23
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update
9:21am
8-K
ytrpr81i
28 Mar 23
Milestone Pharmaceuticals Announces $125 Million Strategic Financing with RTW Investments to Support the Advancement of Etripamil for PSVT
7:00am
8-K
2e49czwzlb
27 Mar 23
Entry into a Material Definitive Agreement
5:17pm
8-K
fc1xhqtw9ya vgfe
10 Mar 23
Regulation FD Disclosure
5:26pm
8-K
srfmjzragthfagvxp0ko
7 Mar 23
Regulation FD Disclosure
9:12am
8-K
8fl32jrtj r7k4sn1z
6 Dec 22
Departure of Directors or Certain Officers
4:37pm